Last, imaging (and therapy) of other GRPR-expressing tumour entities including breast cancer and gastrointestinal stromal tumours might further broaden the scope of applications for [99mTc]Tc-N4-BTG beyond prostate cancer [29–32]. This evidence concerns the gene GRPR and breast cancer.